For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...
Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...
On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...
Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
Dr. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...
The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the ...
Because he can masterfully feign concern over evidence and data, Dr. Prasad is the Shohei Ohtani of spreading doubt and mistrust about vaccines. It's no surprise that under his "leadership", disease ...
Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback